Skip to main content
. 2022 Jan 13;19(7):475–495. doi: 10.1038/s41569-021-00665-7

Fig. 2. Viscoelastometry tracings.

Fig. 2

Rotational thromboelastometry tracings from a healthy individual (part a) and a critically ill patient with coronavirus disease 2019 (COVID-19) (part b). The patient with COVID-19 has more rapid coagulation, as shown by the shortened clotting time (X) and clot formation time (Y), increased maximum amplitude, greater fibrin clot strength (maximum clot firmness; MCF) and the complete absence of fibrinolysis (‘fibrinolysis shutdown’). LY30, lysis achieved by 30 min after clotting time.